ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 166 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $9,525,000 | +28.2% | 300,000 | 0.0% | 4.38% | +21.7% |
| Q3 2014 | $7,428,000 | +163.0% | 300,000 | +140.0% | 3.60% | +147.0% |
| Q2 2014 | $2,824,000 | -42.0% | 125,000 | -37.5% | 1.46% | -40.1% |
| Q1 2014 | $4,866,000 | +11.3% | 200,000 | +14.3% | 2.43% | +14.6% |
| Q4 2013 | $4,373,000 | +6.1% | 175,000 | +16.7% | 2.12% | -11.6% |
| Q3 2013 | $4,121,000 | +127.1% | 150,000 | +50.0% | 2.40% | +114.1% |
| Q2 2013 | $1,815,000 | – | 100,000 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |